Updated: Lawsuit accuses UPenn and Jim Wilson of secretly profiting from former postdoc’s work

A for­mer re­searcher from Jim Wil­son’s gene ther­a­py lab at the Uni­ver­si­ty of Penn­syl­va­nia has sued Wil­son and the uni­ver­si­ty for prof­it­ing off her in­ven­tions with­out her knowl­edge and sab­o­tag­ing her at­tempts to com­mer­cial­ize the tech­nol­o­gy her­self.

Su­san Faust, who was a post­doc­tor­al re­searcher in Wil­son’s gene ther­a­py pro­gram from 2010 to ear­ly 2013, and her biotech Nx­GEN Vec­tor So­lu­tions said that Wil­son and UPenn “con­cealed” li­cens­ing agree­ments for her patents, in­clud­ing a 2016 deal with Bio­gen worth up to $2 bil­lion. She was the on­ly un­com­pen­sat­ed in­ven­tor in that deal, the law­suit said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.